1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 486 F.Supp.2d
  5. 486 F.Supp.2d 241 (2007)
 

IN RE RIVASTIGMINE PATENT LIT. (MDL NO. 1661)

No. 05 MD 1661(HB)(JCF).

486 F.Supp.2d 241 (2007)

In re RIVASTIGMINE PATENT LITIGATION (MDL NO. 1661).

United States District Court, S.D. New York.

April 6, 2007.

Attorney(s) appearing for the Case

Barry S. White, James K. Stronski, H. Sarah Park, Frommer Lawrence & Haug LLP, New York City, for Watson Pharmaceuticals, Inc. and Watson Labs., Inc.

Robert L. Baechtold, Diego Scambia, Nicholas N. Kallas, Fitzpatrick, Cella, Harper & Scinto, New York City, for Novartis Pharmaceuticals Corp., Novartis AG, Novartis Pharma AG, Novartis Int'l Pharmaceutical, Ltd., and Proterra AG.

MEMORANDUM AND ORDER

FRANCIS, United States Magistrate Judge.

A dispute has arisen in this patent case over the obligation of a party under Rule 612 of the Federal Rules of Evidence to disclose privileged documents that have been reviewed by a deposition witness. Dr. Wanda Williams was designated to testify on behalf of defendants Watson Pharmaceuticals, Inc. and Watson Laboratories, Inc. (collectively, "Watson") pursuant to Rule 30(b)(6) of the Federal...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases